Funded Startups in Laval
Among the 7 most recent funded startups listed for Laval, the only clearly large disclosed round is Bellus Health’s $200M Post-IPO Equity on 2021-12-14; th…
Among the 7 most recent funded startups listed for Laval, the only clearly large disclosed round is Bellus Health’s $200M Post-IPO Equity on 2021-12-14; the next-largest disclosed amount shown is Omnirobotic’s $5M (2020-09-24), so the $200M figure dwarfs the rest of the disclosed values. Disclosed amounts are sparse and, where they exist, they cluster below $1M–$70K: Dispersa closed $70K on 2025-07-17 and Propals closed $1M on 2024-05-13.
The list is also shaped by limited visibility on round sizing and a tight recent window: 5 of 7 entries are labeled “Series Unknown,” and 2 of 7 are “undisclosed” on amount (Thryv Therapeutics on 2025-09-17 and AMB Modulaire on 2023-07-17, with Urbanimmersive on 2022-10-11 also “undisclosed”). Dates span 2020-09-24 (Omnirobotic) through the newest entry on 2025-09-17 (Thryv Therapeutics). Sectors cluster most heavily in Biotechnology (4 of 7: Thryv Therapeutics, Dispersa, Bellus Health, and Propals).
Most recent rounds
7 shownRelated listings
Frequently asked
What’s the largest disclosed round in the Laval list, and how much larger is it than the other disclosed amounts?
Bellus Health’s $200M Post-IPO Equity round on 2021-12-14 is the only disclosed amount in a $50M+ range shown here, while the next-largest disclosed figure is Omnirobotic’s $5M on 2020-09-24.
Is there a recent date cluster among these Laval rounds, or are they spread out?
Dates span 2020-09-24 to 2025-09-17, but the most recent entries are concentrated in 2024–2025: Dispersa (2025-07-17, $70K) and Thryv Therapeutics (2025-09-17, undisclosed) sit alongside Propals (2024-05-13, $1M).
How is the stage/round classification distributed across the list?
“Series Unknown” appears in 5 of 7 entries (Thryv Therapeutics 2025-09-17, Dispersa 2025-07-17, Propals 2024-05-13, AMB Modulaire 2023-07-17, and Bellus Health is not labeled that way but Omnirobotic is blank), while Post-IPO Equity appears in 2 of 7 entries (Urbanimmersive 2022-10-11 and Bellus Health 2021-12-14).
Which sectors are over-represented in this Laval slice?
Biotechnology accounts for 4 of 7 entries (Thryv Therapeutics, Dispersa, Bellus Health, and Propals), making it the dominant sector compared with Commerce and Shopping (2 of 7: AMB Modulaire and Urbanimmersive) and Artificial Intelligence (1 of 7: Omnirobotic).
Are there notable outliers in disclosed amounts or sector mix?
Bellus Health’s $200M (2021-12-14) is an outlier versus the rest of the disclosed amounts, which stay at $70K (Dispersa, 2025-07-17) and $1M (Propals, 2024-05-13), and the list also includes three “undisclosed” amounts (Thryv Therapeutics 2025-09-17, AMB Modulaire 2023-07-17, Urbanimmersive 2022-10-11).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.